Compounds > 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid

Page last updated: 2024-09-03

1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid and Lymphoma

1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid has been researched along with Lymphoma in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (75.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (25.00)	2.80

Authors

Authors	Studies
Kang, HJ; Lee, I; Lee, KC; Lim, I; Lim, SM	1
Endo, K; Hanaoka, H; Higuchi, T; Iida, Y; Ishikita, T; Oriuchi, N; Paudyal, B; Paudyal, P; Tominaga, H; Yoshioka, H	1
DeNardo, GL; DeNardo, SJ; Hartmann-Siantar, C; Lam, KS; Lamborn, KR; Miers, LA; Peterson, JJ	1
Bander, NH; Borchardt, P; Curcio, MJ; Frank, RK; Lai, LT; Ma, D; McDevitt, MR; Miederer, M; Pellegrini, V; Scheinberg, DA; Simon, J; Wu, K	1

Other Studies

4 other study(ies) available for 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid and Lymphoma

Article	Year
64 Cu-DOTA-Rituximab PET/CT of B-Cell Non-Hodgkin Lymphoma for Imaging the CD20 Expression. Clinical nuclear medicine, 2023, Feb-01, Volume: 48, Issue:2 Topics: Aged; Antibodies, Monoclonal, Murine-Derived; Fluorodeoxyglucose F18; Humans; Lymphoma; Lymphoma, Non-Hodgkin; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Rituximab	2023
Dual functional molecular imaging probe targeting CD20 with PET and optical imaging. Oncology reports, 2009, Volume: 22, Issue:1 Topics: Animals; Antibodies, Monoclonal; Antigens, CD20; Cell Line, Tumor; Chelating Agents; Copper Radioisotopes; Feasibility Studies; Female; Fluorescent Dyes; Heterocyclic Compounds, 1-Ring; Humans; Lymphoma; Mice; Mice, Inbred BALB C; Mice, Nude; Molecular Probe Techniques; Positron-Emission Tomography; Reproducibility of Results; Spectroscopy, Near-Infrared; Succinimides; Time Factors	2009
Preclinical evaluation of cathepsin-degradable peptide linkers for radioimmunoconjugates. Clinical cancer research : an official journal of the American Association for Cancer Research, 2003, Sep-01, Volume: 9, Issue:10 Pt 2 Topics: Animals; Antibodies, Monoclonal; Breast Neoplasms; Cathepsins; Chelating Agents; Chromatography, High Pressure Liquid; Heterocyclic Compounds, 1-Ring; Humans; Immunoconjugates; Indium Radioisotopes; Linear Models; Liver; Lymphoma; Mice; Mice, Nude; Models, Chemical; Neoplasm Transplantation; Peptides; Radioimmunotherapy; Time Factors	2003
Tumor therapy with targeted atomic nanogenerators. Science (New York, N.Y.), 2001, Nov-16, Volume: 294, Issue:5546 Topics: Actinium; Alpha Particles; Animals; Antibodies, Monoclonal; Female; Half-Life; Heterocyclic Compounds, 1-Ring; Humans; Immunoconjugates; Linear Energy Transfer; Lymphoma; Male; Mice; Mice, Nude; Neoplasm Transplantation; Neoplasms; Prostate-Specific Antigen; Prostatic Neoplasms; Radioimmunotherapy; Survival Rate; Tumor Cells, Cultured	2001